Genetic characterization of thymoma

[1]  S. Galimberti,et al.  GTF2I Mutations Are Common in Thymic Epithelial Tumors But Not in Hematological Malignancies. , 2017, Anticancer research.

[2]  J. Palazzo,et al.  MCM2 expression in serrated polyps demonstrates aberrant cellular proliferation. , 2017, Human pathology.

[3]  S. Takai,et al.  Thymoma with immunodeficiency/Good syndrome associated with myasthenia gravis. , 2017, Rinsho shinkeigaku = Clinical neurology.

[4]  M. Buck,et al.  A role of the SAM domain in EphA2 receptor activation , 2017, Scientific Reports.

[5]  Sylvie Mader,et al.  MCM2: An alternative to Ki-67 for measuring breast cancer cell proliferation , 2017, Modern Pathology.

[6]  Yiping Zhang,et al.  Rare frequency of gene variation and survival analysis in thymic epithelial tumors , 2016, OncoTargets and therapy.

[7]  G. Giaccone,et al.  Multiorgan autoimmune manifestations associated with thymoma. , 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[8]  D. Pironi,et al.  Thymectomy and systemic lupus erythematosus (SLE). , 2014, Annali italiani di chirurgia.

[9]  A. Torkamani,et al.  ASXL1 and DNMT3A mutation in a cytogenetically normal B3 thymoma , 2014, Oncogenesis.

[10]  A. Tangoku,et al.  Methylation and expression profiles of MGMT gene in thymic epithelial tumors. , 2014, Lung cancer.

[11]  P. Marrack,et al.  Ikaros promotes rearrangement of TCR α genes in an Ikaros null thymoma cell line , 2013, European journal of immunology.

[12]  H. Tsujimoto,et al.  Molecular cloning and expression analysis of the canine chemokine receptor CCR9. , 2012, Veterinary immunology and immunopathology.

[13]  Qinghua Zhou,et al.  Thymoma with pure red cell aplasia and Good's syndrome. , 2011, The Annals of thoracic surgery.

[14]  Y. Shoenfeld,et al.  Thymoma and autoimmunity , 2011, Cellular and Molecular Immunology.

[15]  M. Krasna,et al.  Different Characteristics of Thymomas With and Without Myasthenia Gravis , 2011, Annals of Surgical Oncology.

[16]  D. Ribatti,et al.  SOX2 gene expression in normal human thymus and thymoma , 2011, Clinical and Experimental Medicine.

[17]  A. Tessitore,et al.  Thirty-five-year follow-up analysis of clinical and pathologic outcomes of thymoma surgery. , 2010, The Annals of thoracic surgery.

[18]  N. Girard,et al.  Comprehensive Genomic Analysis Reveals Clinically Relevant Molecular Distinctions between Thymic Carcinomas and Thymomas , 2009, Clinical Cancer Research.

[19]  B. Leggett,et al.  Epigenetic silencing of EphA1 expression in colorectal cancer is correlated with poor survival , 2009, British Journal of Cancer.

[20]  W. Yang,et al.  Genome-wide genetic aberrations of thymoma using cDNA microarray based comparative genomic hybridization , 2007, BMC Genomics.

[21]  T. Tsuji,et al.  Malignant transformation of thymoma in recipient rats by heterotopic thymus transplantation from HTLV-I transgenic rats , 2005, Laboratory Investigation.

[22]  Yuetsu Tanaka,et al.  A novel animal model of thymic tumour: Development of epithelial thymoma in transgenic rats carrying human T lymphocyte virus type I pX gene , 2002, International journal of experimental pathology.

[23]  C. Angelini,et al.  Detection of HTLV-I tax-rex and pol gene sequences of thymus gland in a large group of patients with myasthenia gravis. , 2002 .

[24]  N. Græm,et al.  Expression of bcl‐2 in fetal thymus, thymomas and thymic carcinomas , 1998, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.